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ABSTRACT
OBJECTIVE
To evaluate the relation between intake of ultraprocessed food and risk of inflammatory bowel
disease (IBD).
DESIGN
Prospective cohort study.
SETTING
21 low, middle, and high income countries across
seven geographical regions (Europe and North
America, South America, Africa, Middle East, south
Asia, South East Asia, and China).
PARTICIPANTS
116 087 adults aged 35-70 years with at least
one cycle of follow-up and complete baseline
food frequency questionnaire (FFQ) data (country
specific validated FFQs were used to document
baseline dietary intake). Participants were followed
prospectively at least every three years.
MAIN OUTCOME MEASURES
The main outcome was development of IBD, including
Crohn’s disease or ulcerative colitis. Associations
between ultra-processed food intake and risk of
IBD were assessed using Cox proportional hazard
multivariable models. Results are presented as hazard
ratios with 95% confidence intervals.
RESULTS
Participants were enrolled in the study between 2003
and 2016. During the median follow-up of 9.7 years
(interquartile range 8.9-11.2 years), 467 participants

WHAT IS ALREADY KNOWN ON THIS TOPIC
Inflammatory bowel disease (IBD) is more common in industrialised nations
It is hypothesised that environmental factors such as diet might influence the
risk of IBD
Many dietary risk factors have been investigated for an association with IBD, but
data for an association between ultra-processed food (which contain additives
and preservatives) intake and IBD are limited

WHAT THIS STUDY ADDS
A higher intake of ultra-processed food was associated with higher risk of IBD
Individual food categories (meats, dairy, starches, fruit, and vegetables) were
not associated with risk of IBD, suggesting that risk might be related to the food
itself rather than the way it is processed or ultra-processed
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developed incident IBD (90 with Crohn’s disease
and 377 with ulcerative colitis). After adjustment
for potential confounding factors, higher intake of
ultra-processed food was associated with a higher risk
of incident IBD (hazard ratio 1.82, 95% confidence
interval 1.22 to 2.72 for ≥5 servings/day and 1.67,
1.18 to 2.37 for 1-4 servings/day compared with <1
serving/day, P=0.006 for trend). Different subgroups
of ultra-processed food, including soft drinks, refined
sweetened foods, salty snacks, and processed meat,
each were associated with higher hazard ratios for
IBD. Results were consistent for Crohn’s disease and
ulcerative colitis with low heterogeneity. Intakes
of white meat, red meat, dairy, starch, and fruit,
vegetables, and legumes were not associated with
incident IBD.
CONCLUSIONS
Higher intake of ultra-processed food was positively
associated with risk of IBD. Further studies are needed
to identify the contributory factors within ultraprocessed foods.
STUDY REGISTRATION
ClinicalTrials.gov NCT03225586.

Introduction
Inflammatory bowel disease (IBD), comprised of
Crohn’s disease and ulcerative colitis, is a chronic
inflammatory disorder of the gastrointestinal tract.
The pathophysiology of IBD is thought to be related
to activation of the intestinal mucosal immune system
in response to dysbiosis of the gastrointestinal tract
in genetically susceptible people.1 Diet alters the
microbiome2 and modifies the intestinal immune
response and so could play a role in the pathogenesis
of IBD.3 The incidence of IBD has increased in several
countries where both diseases were previously
uncommon.4 This increase has paralleled the adoption
of a western diet in these countries. Dietary changes
in such countries, including increased intake of refined
sugars and dietary fats such as n-6 polyunsaturated
fatty acids and decreased intake of fibre, have been
suggested as potential risk factors for the development
of IBD.5-7
Specific data linking dietary factors with IBD
in human populations have been limited and
conflicting.8-10 Most previous studies of diet and IBD
1
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Methods
The design and methods of the PURE study have been
described and published previously.23-25 The first
and second phases of the study took place between
1 January 2003 and 31 December 2016 and included
136 384 adults aged 35-70 years who had dietary
information assessed. Participants were enrolled
from 21 countries: Argentina, Bangladesh, Brazil,
Canada, Chile, China, Colombia, India, Iran, Malaysia,
Palestine, Pakistan, Philippines, Poland, South Africa,
Saudi Arabia, Sweden, Tanzania, Turkey, United
Arab Emirates, and Zimbabwe. The sampling and
2

recruitment strategies from PURE have been published
previously (see supplementary appendix 1).26 Data
were collected at the community, household, and
individual level using standardised questionnaires.
Standard case report forms were used to record new
diagnoses of Crohn’s disease and ulcerative colitis
during the follow-up period. For the current analysis,
the data include all outcome events up to 5 July
2019. The Population Health Research Institute and
McMaster University and Hamilton Health Sciences in
Hamilton, Ontario, Canada coordinated the study.

Procedures
For each participant in PURE, usual food intake was
assessed at baseline using country specific validated
food frequency questionnaires (FFQ). Validated
FFQs were developed for countries where such
questionnaires had not been available previously
(supplementary table 1). Participants received a list of
food items and were asked to input their frequency for
intake of each item in the past year. To compute daily
food and nutrient intakes, participant’s answers were
converted to daily intake and multiplied by United
States Department of Agriculture (USDA) serving size.
Ultra-processed food included all types of packaged
and formulated foods and beverages that contain
food additives, artificial flavourings, colours, or other
chemical ingredients. Included in this group were
processed meat, cold breakfast cereal, various types of
sauce, soft drinks, refined sweetened foods (eg, candy,
chocolate, jam, jelly, brownies, pudding), chips, ice
cream, commercially prepared pastries, biscuits, and
fruit drinks. To make the unit of consumption consistent
between countries, we used daily serving intake.
Outcomes
The primary outcome was the development of IBD
after completion of the baseline questionnaire. Other
outcomes of interest were development of Crohn’s
disease and ulcerative colitis individually by dietary risk
factors that had statistically significant associations
with the development of IBD overall. Although data
collection for PURE started in 2003, an amendment
was implemented in 2014 to record diagnoses of
Crohn’s disease and ulcerative colitis. Participants
were asked at every follow-up questionnaire whether
they had a diagnosis of Crohn’s disease or ulcerative
colitis. They were asked when the condition was
diagnosed and those with prevalent diagnoses of
IBD (diagnosis before baseline questionnaire) were
excluded. Participants were also excluded if their
baseline FFQ was completed less than one year from
the time of the reported IBD diagnosis. Participants
self-reported the diagnosis. A validation exercise was
conducted to validate 20% of the diagnoses using a
sample of the population where medical records could
be provided for review by the authors.
Statistical analysis
Continuous variables are expressed as means with
standard deviation, and categorical variables are
doi: 10.1136/bmj.n1554 | BMJ 2021;374:n1554 | the bmj
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have used retrospective or case-control designs.9 10 The
few prospective studies that have examined dietary
risk factors have been limited by small numbers
of participants, lack of adjustment for potential
confounders, or use of homogenous populations
confined to individual countries or specific regions of
countries.6 7 11-15
A recent systematic review synthesised all studies
that evaluated dietary intake and risk of IBD.10 It was
evident from the findings that many associations have
been examined repeatedly, including the association
of different dietary fats, carbohydrates, proteins, fruit,
vegetables, fibre, and dairy with IBD.10 Meats have been
assessed as a whole, with some, but not all, studies
suggesting an increased odds for the development of
IBD with higher meat intake.10 16 The systematic review
also found high intake of total fats, polyunsaturated
fatty acids, and omega-6 fatty acids to be associated
with increased risk of IBD. High fibre and fruit intake
might decrease the risk of Crohn’s disease, and high
vegetable intake was associated with a decreased risk
of ulcerative colitis.17 18
Recent attention has focused on the non-nutritional
components of diet and potential associated risks.
Processed foods often include many non-natural
ingredients and additives such as artificial flavours,
sugars, stabilisers, emulsifiers, and preservatives.
Detergents and emulsifiers that are added to foods
might have a detrimental effect on the gut barrier.
Carboxymethylcellulose has been shown to increase
bacterial adherence to intestinal epithelium and might
lead to bacterial overgrowth and infiltration of bacteria
into the spaces between intestinal villi.19 Polysorbate
80, an emulsifier commonly used in processed foods,
increases translocation of bacteria such as Escherichia
coli across M cells and Peyer’s patches in people with
Crohn’s disease.20 Associations have been reported
between diets high in processed foods and development
of diseases such as cancer and cardiovascular
disease.21 22 One recent study investigated whether
ultra-processed foods were associated with risk of IBD
and did not find any association, but this study was
limited by few patients with IBD (75 among 105 832
participants).15
Using information from the Prospective Urban
Rural Epidemiology (PURE) cohort, we describe the
association between ultra-processed food intake and
risk of developing IBD.24-26
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servings/day, 2-5 servings/day, and ≥6 servings/day
and were also analysed separately. Lastly, fried foods
were categorised into none, 1 serving/week to <1
serving/day, or ≥1 servings/day.
We calculated hazard ratios using multivariable Cox
proportional hazard models. Estimates of hazard ratios
and 95% confidence intervals are presented for each
dietary risk factor of interest. Results are presented
as unadjusted hazard ratios, minimally adjusted
hazard ratios for age, sex, and geographical region,
and fully adjusted hazard ratios. Covariates included
in the fully adjusted model were those known from
previous literature to have an association with the
development of IBD (eg, smoking) or those found to
have an association on univariable analyses (P<0.15).
Covariates for consideration in the fully adjusted
multivariable model included age, sex, geographical
region, education, alcohol intake, smoking status,
physical activity, energy intake, BMI, waist to hip
ratio, and urban versus rural location. An additional
model was run including adjustment for diet quality
as measured by the Alternate Health Eating Index
(AHEI).28 The Kolmogorov-type Supremum test was
used to test the proportional hazards assumptions.29
The χ2 test of linear trend was used to compare
across categories of food intake. A two sided P<0.05
was considered to be statistically significant.
Sensitivity analysis were conducted by using multiple
imputation for participants with missing FFQ data
to determine whether this had any impact on the
results. For separate analyses of Crohn’s disease
and ulcerative colitis conducted when a dietary risk
factor had statistically significant association with
development of IBD, we anticipated lower power to
achieve statistical significance separately within each
subgroup. For comparison of subgroup effects, we
assessed heterogeneity by calculating the χ2 and I2
statistics. For the χ2 test, we considered a P value of
<0.10 to be statistically significant. I2 values greater
than 50% were considered to indicate substantial
heterogeneity. We used heterogeneity of the subgroup
analyses to determine whether the association was
predominantly due to effect from one subgroup. Data
were analysed using Stata/IC 15.

Patient and public involvement
No patients were involved in setting the research
question or outcome measures, or in the design and
implementation of this study.
Results
Between 1 January 2003 and 31 December 2016, a
total of 153 220 participants completed the FFQ. Of
these participants, 126 662 had a plausible energy
intake (500-5000 kcal/day; 1 kcal=4.18 kJ or 0.00418
MJ) and had at least one cycle of follow-up. Overall,
10 625 (8.3%) were excluded owing to incomplete FFQ
data, leaving a total of 116 037 participants included
in this study.
During a median follow-up of 9.7 years (interquartile
range 8.9-11.2 years), 467 participants (0.4%) had a
3
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expressed as percentages. Education was categorised
as college, university, or trade (age >11 years),
secondary or high school (age 7-11 years), or none or
primary school (age <6 years). Alcohol was categorised
as <1 serving/month (eg, per serving: beer 14 g, wine
16 g, vodka, rum, spirits 10 g, liqueur 27 g), 1 serving/
month to 1/week, or >1 serving/week. Geographical
region was treated as binary variable of North America
and Europe or rest of the world because the prevalence
of IBD is typically highest in North America and
Europe and lower in other parts of the world. Other
binary variables included smoking status (current
versus no smoking) and location (rural versus urban).
Other categorical variables included body mass
index, classified as obese, overweight, or normal, and
physical activity, classified as low (<600 metabolic
equivalent of task (MET) min/week), moderate (6003000 MET min/week), or high (>3000 MET min/week).
Continuous variables included age, daily total energy
(in kcal), and waist to hip ratio.
For the overall analysis of total ultra-processed food,
participants were grouped into categories according
to servings as <1 serving/day, 1-4 servings/day, or ≥5
servings/day. The lowest intake group was always used
as the reference group. In a sensitivity analysis, we also
grouped participants based on grams of intake of ultraprocessed food into <50 g/day, 50-99 g/day, and ≥100 g/
day. We also assessed the association using categories
of ultra-processed foods individually. Processed meat
was categorised into <1 serving/week, 1-6 servings/
week, or ≥7 servings/week. Soft drink intake was
categorised into <0.5 serving/week, 0.5 to <3 servings/
week, or ≥3 servings/week. Refined sweetened foods—
those high in refined sugars (eg, cake, cookies)—and
intake was categorised as none, 1-99 g/day, or ≥100 g/
day. Salty foods and snacks (eg, crackers, potato chips,
nachos, popcorn) were categorised into <50 g/day, 5099 g/day, and ≥100 g/day. An additional analysis of
urinary sodium was conducted, as a surrogate of dietary
sodium, to determine whether dietary sodium could
potentially be implicated should ultra-processed foods
be associated with risk of IBD. The Kawasaki formula
was used to estimate urinary sodium excretion.27
Based on a previous study assessing urinary sodium,
categories chosen were <2.5 g/day, 2.5-3.4 g/day,
and ≥3.5 g/day.27 A sensitivity analysis was planned
to exclude China because of its significantly higher
observed sodium intake compared with the rest of the
world and relatively low event rates for IBD.27
Exploratory analyses were planned with other
dietary variables to confirm or refute risk factors
that had been reported in the literature as showing
associations. Participants were categorised by white
meat intake into <1 serving/week, 1-2 servings/week,
or ≥3 servings/week. Red meat (unprocessed) was
categorised into <3 servings/week, 3-6 servings/week,
or ≥7 servings/week. Dairy intake was categorised into
<1 serving/day, 1 to <2 servings/day, or ≥2 servings/
day. Starch intake was categorised into <200 g/day,
200-399 g/day, and ≥400 g/day. Fruit, vegetables, and
legumes were analysed together and classified as <2

4

1 kcal=4.18 kJ or 0.00418 MJ.
*Urinary sodium was used as a surrogate for sodium intake.

Characteristics
Diagnosis of IBD
Crohn’s disease
Ulcerative colitis
Mean (SD) age (years)
Women
Urban setting
Current smoker
Mean (SD) energy intake (kcal)
Mean (SD) ultra-processed food (servings/day)
Mean (SD) ultra-processed food (g/day)
Mean (SD) processed meat (servings/week)
Mean (SD) soft drinks (servings/week)
Mean (SD) refined sweetened foods (g/day)
Mean (SD) salty foods or snacks (g/day)
Mean (SD) sodium (g/day)*

Overall
(n=116 037)
467 (0.4)
90 (0.1)
377 (0.3)
50.2 (9.7)
68 732 (59.2)
60 412 (52.1)
22 563 (19.6)
2161 (812)
1.8 (3.9)
94.2 (228.3)
1.2 (2.8)
1.2 (4.0)
92.0 (216.3)
28.4 (37.6)
4.1 (1.6)

Europe and
North America
(n=17 232)
192 (1.1)
51 (0.3)
141 (0.8)
52.7 (9.2)
9766 (56.7)
11 925 (69.2)
2820 (16.4)
2277 (832)
6.0 (7.3)
220.9 (255.1)
2.8 (3.7)
2.0 (4.3)
99.9 (138.1)
57.9 (50.0)
3.6 (1.6)

South America
(n=18 611)
33 (0.2)
5 (0)
28 (0.2)
51.0 (9.5)
11 655 (62.6)
10 489 (56.4)
3673 (19.8)
2198 (794)
2.9 (3.7)
238.4 (416.8)
2.2 (4.0)
3.8 (7.8)
306.1 (418.2)
35.7 (35.5)
4.7 (1.4)

Africa (n=3871)
25 (0.6)
4 (0.1)
21 (0.5)
50.0 (10.1)
2897 (74.9)
1772 (45.8)
807 (21.4)
2084 (965)
0.7 (1.0)
83.4 (184.3)
1.8 (2.5)
1.7 (3.8)
61.6 (139.7)
38.5 (52.0)
4.2 (1.5)

Middle East
(n=9399)
103 (1.1)
5 (0.1)
98 (1.0)
47.8 (9.2)
4951 (52.7)
5298 (56.4)
1323 (14.1)
2322 (827)
1.2 (1.4)
88.7 (159.3)
0.6 (1.3)
0.8 (1.6)
103.0 (180.1)
29.8 (29.2)
4.6 (1.7)

South Asia
(n=21 834)
94 (0.4)
24 (0.1)
70 (0.3)
47.3 (9.8)
12 879 (59.0)
9110 (41.7)
4847 (22.3)
2115 (829)
0.3 (1.2)
14.5 (56.1)
0.01 (0.1)
0.2 (0.9)
25.8 (44.3)
6.5 (16.4)
3.4 (1.7)

South East Asia
(n=8998)
1 (0.01)
0
1 (0)
51.4 (9.7)
5503 (61.2)
4472 (49.7)
1320 (14.8)
2552 (987)
2.0 (2.1)
73.7 (95.7)
0.3 (0.5)
1.5 (3.2)
100.5 (122.5)
55.6 (46.7)
3.8 (1.2)

Participants who
developed IBD
China (n=36 092) (n=467)
19 (0.1)
1 (0)
18 (0.1)
50.8 (9.7)
50.5 (9.3)
21 081 (58.4)
273 (58.5)
17 346 (48.1)
276 (59.1)
7773 (21.9)
75 (16.1)
1984 (664)
2105 (775)
0.3 (1.0)
4.0 (6.8)
15.0 (58.4)
145.4 (223.2)
0.2 (0.6)
2.2 (3.3)
0.1 (0.3)
1.5 (3.4)
17.2 (34.1)
100.4 (180.6)
16.0 (20.3)
39.9 (47.2)
5.7 (1.9)
4.2 (1.5)

diagnosis of incident IBD (supplementary figure 1):
90 participants with Crohn’s disease and 377 with
ulcerative colitis. Supplementary appendix 2 provides
the results of the validation exercise.
Ultra-processed food intake was higher in North
America, Europe, and South America than in other
regions (table 1), both in servings and grams of intake
daily. Similarly, processed meat and soft drink intakes
were highest in these three regions. Consumption of
refined sweetened foods was highest in South America,
followed by the Middle East and South East Asia. Salty
and snack food intake was highest in North America
and South East Asia. Sodium intake was highest in
China.
Table 2 summarises the results of the univariable
associations. Those dietary variables that were
nominally significant were included in the multivariable
Cox proportional hazard regression models. In
addition to age, sex, and geographical region used
in the minimally adjusted model, education, alcohol
intake, smoking status, BMI, total energy intake, and
location were all found to be significantly associated
with the development of IBD and were included within
the multivariable model. None of the variables in the
model violated the proportional hazards assumption
(P>0.05) when tested using the Supremum test for total
ultra-processed food intake, individual categories of
ultra-processed food intake, urinary sodium, and other
food categories, and the outcome of IBD development.

Ultra-processed food intake and risk of IBD
Table 3 shows the graded association between intake
of total ultra-processed foods and risk of IBD. Higher
intake of ultra-processed food was associated with a
higher risk of incident IBD (hazard ratio 1.82, 95%
confidence interval 1.22 to 2.72 for ≥5 servings/day
and 1.67, 1.18 to 2.37 for 1-4 servings/day compared
with <1 serving/day, P=0.006 for trend). When further
adjusted using the AHEI, findings were similar, as
higher risk of IBD was observed for ≥5 servings/day
(1.92, 1.28 to 2.90) and 1-4 servings/day (1.75, 1.23
to 2.50) compared with <1 serving/day (P=0.004
for trend). The results were directionally consistent
for Crohn’s disease and ulcerative colitis, with no
statistical evidence of heterogeneity (χ2 P=0.60;
I2=0%). In sensitivity analysis (supplementary table
2), the risk of IBD development in participants with
ultra-processed food intake (g/day) was also found
to be significantly increased. Higher intake (g/day) of
ultra-processed food was associated with higher risk
of incident IBD (1.73, 1.23 to 2.45 for ≥100 g/day and
1.33, 0.88 to 2.01 for 50-100 g/day compared with
<50 g/day, P=0.007 for trend). Sensitivity analysis with
multiple imputation for missing FFQ data also showed
a higher risk of IBD with increased ultra-processed
food intake, suggesting that the missing data did not
alter the findings (table 3). Subgroup analyses were
performed to determine whether participant age was
an effect modifier, but similar patterns of increased
hazard ratios at higher levels of ultra-processed food
intake were observed in participants younger than
doi: 10.1136/bmj.n1554 | BMJ 2021;374:n1554 | the bmj
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Table 1 | Characteristics of study population at enrolment and diagnosis of inflammatory bowel disease (IBD) during follow-up by region. Values are numbers (percentages) unless stated otherwise
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Univariable
Predictors
Age
Sex (men)
North America and Europe
Education:
None
Secondary or high school
College, university, or trade
Alcohol†:
<1 serving/month
1 serving/ month to <1 serving/week
≥1 serving/week
Current smoking
Physical activity (MET score):
Low (<600)
Moderate (600 to <3000)
High (≥3000)
Energy (kcal)
Body mass index:
Normal (<25)
Overweight (25 to <30)
Obese (≥30)
Waist to hip ratio
Location:
Urban
Rural

Multivariable*

Hazard ratio (95% CI)
1.00 (0.99 to 1.01)
1.03 (0.86 to 1.24)
4.04 (3.36 to 4.86)

1.00 (ref)
1.26 (1.01 to 1.58)
2.24 (1.78 to 2.81)
1.00 (ref)
3.52 (2.46 to 5.04)
2.93 (2.28 to 3.77)
0.78 (0.61 to 1.00)
1.00 (ref)
1.28 (0.95 to 1.71)
1.30 (0.98 to 1.74)
1.00 (0.99 to 1.00)
1.00 (ref)
1.09 (0.88 to 1.34)
1.38 (1.09 to 1.75)
1.80 (0.61 to 5.28)
1.00 (ref)
0.75 (0.62 to 0.90)

P value
0.51
0.73
<0.001
<0.001

<0.001

0.05
0.16

0.13
0.03

0.28
0.002

Hazard ratio (95% CI)
1.01 (0.99 to 1.02)
0.93 (0.72 to 1.20)
5.57 (3.97 to 7.81)

1.00 (ref)
1.60 (1.13 to 2.26)
1.57 (1.07 to 2.26)
1.00 (ref)
1.21 (0.82 to 1.80)
0.92 (0.67 to 1.26)
0.73 (0.51 to 1.06)

1.00 (0.99 to 1.00)
1.00 (ref)
0.91 (0.69 to 1.19)
0.96 (0.70 to 1.32)

1.00 (ref)
0.99 (0.76 to 1.28)

P value
0.16
0.59
<0.001
0.02

0.34

0.10

0.08
0.78

0.91

MET=metabolic equivalent of task.
*Ultra-processed food intake in servings per day was used as main predictor.
†For example, per serving: beer 14 g, wine 16 g, vodka, rum, spirits 10 g, liqueur 27 g.

50 and 50 or older (supplementary tables 3 and 4).
Region specific analyses (supplementary figure 2) were
also performed to determine whether the pattern of
increased ultra-processed food intake and higher risk
of IBD persisted within each of the regions examined,
and effect estimates were generally similar, with
overlapping confidence intervals and no significant
heterogeneity (χ2 P=0.69; I2=0%).
Supplementary table 5 shows that higher processed
meat intake was associated with higher risk of IBD
(2.07, 1.14 to 3.76 for ≥1 serving/day and 1.92, 1.242.98 for 1 serving/week to <1 serving/day compared
with <1 serving/week, P=0.01 for trend; supplementary
tables 5-8). Increased risk was observed for both Crohn’s
disease and ulcerative colitis (tests of heterogeneity: χ2
P=0.93; I2=0%). A graded risk was also found for soft
drinks intake and risk of IBD (supplementary table 6).
The highest intake of soft drinks (≥3 servings/week)
compared with lowest intake (<0.5 serving/week) was
associated with a higher risk of IBD (1.94, 1.42 to
2.66, P<0.001 for trend), with directionally consistent
results observed for Crohn’s disease and ulcerative
colitis and no statistical evidence of heterogeneity (χ2
P=0.72; I2=0%).
Consumption of refined sweetened foods was
associated with higher risk of IBD (supplementary table
7). The highest risk of IBD was observed in participants
with ≥100 g/day intake (2.58, 1.44 to 4.62, P=0.003
for trend) compared with zero intake. Results were
consistent for Crohn’s disease and ulcerative colitis
(tests of heterogeneity: χ2 P=0.17; I2=41%). A similar
the bmj | BMJ 2021;374:n1554 | doi: 10.1136/bmj.n1554

pattern was observed for salty foods and snacks, where
an increased risk of IBD was observed in participants
with ≥100 g/day intake compared with <50 g/day
(2.06, 1.41 to 3.00, P<0.001 for trend; supplementary
table 8). Associations with similar direction were
observed for the risk of Crohn’s disease and ulcerative
colitis, without significant heterogeneity (χ2 P=0.25;
I2=27.8%).

Urinary sodium and risk of IBD
Urinary sodium was used as a surrogate of dietary
sodium intake. The risk of IBD in participants with
higher levels of urinary sodium (≥3.5 g/day) was
found not to be higher than in those patients with the
lowest levels of urinary sodium (<2.5 g/day, P=0.61
for trend; table 4). As a large number of participants
with IBD was found among the highest urinary sodium
cohort, a sensitivity analysis was performed to further
subdivide this cohort (supplementary table 9), but
again no difference in risk of IBD was observed in
those with the highest levels of urinary sodium (≥5 g/
day) compared with those with lower levels (P=0.45
for trend). Although urinary sodium was found to be
highest among participants from China (table 1) with
only 19 incident cases of IBD, the results did not differ
after exclusion of participants from China (P=0.68 for
trend).
Other food categories and risk of IBD
Several other food categories were evaluated in
exploratory analyses (table 5 and table 6, also see
5
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Table 2 | Results from univariable and multivariable analyses of baseline covariates and risk of inflammatory bowel
disease

RESEARCH

Ultra-processed food intake

Inflammatory bowel disease
No of participants
No (%) of events
Unadjusted model
Minimally adjusted model*
Fully adjusted model†
Fully adjusted plus AHEI score model
Sensitivity analysis using multiple imputation‡
Crohn’s disease
No of participants
No (%) of events
Unadjusted model
Minimally adjusted model*
Fully adjusted model†
Fully adjusted plus AHEI score model
Sensitivity analysis using multiple imputation‡
Ulcerative colitis
No of participants
No (%) of events
Unadjusted model
Minimally adjusted model*
Fully adjusted model†
Fully adjusted plus AHEI score model
Sensitivity analysis using multiple imputation‡

<1 serving/day

1-4 servings/day

≥5 servings/day

P trend

76 415
199 (0.26)
1 (ref)
1 (ref)
1 (ref)
1 (ref)
1 (ref)

25 453
134 (0.53)
2.20 (1.77 to 2.74)
1.41 (1.11 to 1.79)
1.67 (1.18 to 2.37)
1.75 (1.23 to 2.50)
1.54 (1.21 to 1.84)

11 742
95 (0.81)
3.18 (2.49 to 4.07)
1.42 (1.07 to 1.90)
1.82 (1.22 to 2.72)
1.92 (1.28 to 2.90)
1.71 (1.22 to 2.37)

<0.001
0.01
0.006
0.004
<0.001

76 415
34 (0.04)
1 (ref)
1 (ref)
1 (ref)
1 (ref)
1 (ref)

25 453
23 (0.09)
2.19 (1.29 to 3.72)
1.15 (0.64 to 2.06)
2.72 (1.06 to 6.97)
2.93 (1.13 to 7.60)
1.30 (0.71 to 2.37)

11 742
30 (0.26)
5.84 (3.57 to 9.54)
1.92 (1.05 to 3.49)
4.50 (1.67 to 12.13)
4.90 (1.78 to 13.45)
2.83 (1.45 to 4.65)

<0.001
0.07
0.01
0.008
0.40

76 415
165 (0.22)
1 (ref)
1 (ref)
1 (ref)
1 (ref)
1 (ref)

25 453
111 (0.44)
2.20 (1.73 to 2.80)
1.48 (1.13 to 1.93)
1.55 (1.06 to 2.28)
1.61 (1.09 to 2.38)
1.59 (1.23 to 1.98)

11 742
65 (0.55)
2.63 (1.97 to 3.51)
1.27 (0.91 to 1.77)
1.46 (0.93 to 2.28)
1.52 (0.96 to 2.41)
1.45 (0.96 to 2.12)

<0.001
0.02
0.08
0.06
<0.001

AHEI=Alternate Healthy Eating Index.
Heterogeneity of results from Crohn’s disease and ulcerative colitis: χ2 P=0.595; I2=0%.
*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total energy intake, and location.
‡To account for participants with missing data on food frequency questionnaire.

supplementary tables 10-18 for detailed analyses).
Intake of white meat, unprocessed red meat, dairy,
starchy foods, and fruit, vegetables, and legumes was
not associated with risk of IBD (supplementary tables
10-17). Intake of fried foods was associated with higher
risk of IBD (supplementary table 18). Those with a
fried food intake of ≥1 servings/day showed the highest
risk of IBD (3.02, 1.51 to 6.03, P=0.006 for trend)
compared with those with zero intake. No significant
difference in risk was observed between Crohn’s
disease and ulcerative colitis (tests of heterogeneity: χ2
P=0.19; I2=37.6%).

Discussion
In this large, multinational, prospective cohort study
involving 116 087 participants from 21 low, middle,
and high income countries, we found that higher
intake of ultra-processed foods was associated with
an increased risk of IBD. This was seen for all ultraTable 4 | Association between urinary sodium intake and risk of inflammatory bowel
disease. Values are hazard ratios (95% confidence intervals) unless stated otherwise
Sodium intake (g/day)

No of participants
No (%) of events
Unadjusted
Minimally adjusted*
Fully adjusted†

<2.5
8444
42 (0.50)
1 (ref)
1 (ref)
1 (ref)

2.5 to <3.5
11 555
73 (0.62)
1.33 (0.91 to 1.95)
1.88 (1.28 to 2.76)
1.26 (0.80 to 1.97)

≥3.5
61 033
269 (0.44)
0.89 (0.64 to 1.23)
1.66 (1.18 to 2.34)
1.17 (0.79 to 1.74)

P trend

0.008
0.004
0.61

*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total
energy intake, and location.

6

processed foods, as well as individual types, including
processed meats, soft drinks, refined sweetened foods,
and salty foods and snacks. No significant heterogeneity
was observed when the results for Crohn’s disease were
compared with the results for ulcerative colitis within
each of these types of ultra-processed foods. These
results remained consistent in sensitivity analyses
using alternative classifications for ultra-processed
food intake and using multiple imputation to account
for missing FFQ data. The results were still consistent
after adjustment for a western diet using the AHEI. Our
findings support the hypothesis that intake of ultraprocessed foods could be an environmental factor that
increases the risk of IBD.

Comparison with other studies
Processed foods are a diverse food group that include
meats, dairy, starchy foods, fruit, vegetables, and
legumes. None of these categories on its own was
found to be implicated as a risk factor for IBD in our
study. Recent attention has focused on diet as an
environmental factor that might be implicated in the
development of IBD, and studies have suggested that
western-type diets that are typically high in protein,
fat, salt, and sugar but low in fruit, vegetables, and
fibre, are associated with increased risk of IBD.30-32
A recent meta-analysis suggested western-type diets
were associated with a relative risk for IBD of 1.92
(95% confidence interval 1.37 to 2.68).33 Western-type
diets, however, also contain higher levels of additives
and preservatives, which could explain the association
doi: 10.1136/bmj.n1554 | BMJ 2021;374:n1554 | the bmj
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Table 3 | Association between total ultra-processed food intake and risk of inflammatory bowel disease. Values are
hazard ratios (95% confidence intervals) unless stated otherwise

≥1
1.26 (0.88 to 1.79)
3.02 (1.51 to 6.03)
<1
1.00 (0.72 to 1.41)
2.35 (1.21 to 4.55)
0
1 (ref)
1 (ref)

Fried foods (servings/day)

P trend
0.21
0.11
*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total energy intake, and location.

≥6
1.23 (0.86 to 1.77)
1.31 (0.77 to 2.22)
2 to <6
1.02 (0.72 to 1.43)
0.97 (0.59 to 1.60)
<2
1 (ref)
1 (ref)

Fruit, vegetables, and legumes (servings/day)

P trend
0.43
0.16
≥400
1.23 (0.89 to 1.71)
1.50 (0.95 to 2.38)
200 to <400
1.22 (0.89 to 1.67)
1.41 (0.98 to 2.04)

Starch (g/day)

<200
1 (ref)
1 (ref)
Model
Minimally adjusted*
Fully adjusted†

*Adjusted for age, sex, and geographical region.
†Adjusted for age, sex, geographical region, education, alcohol intake, smoking status, body mass index, total energy intake, and location.

Table 6 | Summary of associations between starch; fruit, vegetables, and legumes; and fried foods intake and risk of inflammatory bowel disease. Values are hazard ratios (95% confidence
intervals) unless stated otherwise

P trend
0.006
0.49
≥2
1.50 (1.15 to 1.96)
1.26 (0.86 to 1.83)
1 to <2
1.06 (0.80 to 1.41)
1.14 (0.78 to 1.68)
<1
1 (ref)
1 (ref)

Dairy (servings/day)

P trend
0.18
0.72
≥7
1.03 (0.82 to 1.30)
1.12 (0.81 to 1.53)
3 to <7
0.83 (0.65 to 1.05)
1.00 (0.74 to 1.35)
<3
1 (ref)
1 (ref)

Red meat (servings/week)

P trend
0.46
0.10
≥3
1.06 (0.82 to 1.36)
1.38 (0.97 to 1.95)
1 to <3
1.16 (0.92 to 1.45)
1.31 (0.99 to 1.74)

White meat (servings/week)

<1
1 (ref)
1 (ref)
Model
Minimally adjusted*
Fully adjusted†

Table 5 | Summary of associations between meat and dairy intake and risk of inflammatory bowel disease. Values are hazard ratios (95% confidence intervals) unless stated otherwise
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with higher risk of IBD. We hypothesised that increased
sodium intake could be implicated, as various animal
models have shown increased dietary sodium to
be associated with exacerbation of autoimmune
conditions, including collagen induced rheumatoid
arthritis34 and 2,4,6-trinitrobenzenesulfonic acid
induced colitis for IBD.35 In our study, however, we
found no relation between urinary sodium, a surrogate
for dietary sodium intake, and development of IBD.
This suggests that components other than sodium in
ultra-processed foods might be responsible for the
higher risk of IBD observed with higher consumption
of salty snacks.
Further studies are required to identify potential
contributory factors in ultra-processed foods.
Preclinical studies in mice models found that
emulsifiers, which are widely used in western diets and
include carboxymethylcellulose and polysorbate 80,
induce thinning of the mucosal layer and dysbiosis and
promote development of colitis and colitis associated
colon cancer.36-38 In preclinical studies other additives
that have been implicated include maltodextrin39 40
and titanium dioxide.41 Intake of foods containing
these types of additives could be a plausible pathway
for disruption of gut microbiota and propagation of the
subsequent immune activation that occurs in IBD.
Recent studies have assessed the association
between processed food intake and IBD. One study
from Romania and Belgium reported that participants
with IBD were more likely to report higher intake of
refined sweetened foods, processed and high fat meats,
fried food, salt, ice cream, mayonnaise, margarine,
and chips or other snacks compared with healthy
controls. A US study using data from the National
Health Interview Study in 2015 reported higher intake
of cheese, cookies, French fries, sports drinks, and
soda among participants with IBD compared with no
IBD. These studies, however, had design limitations,
including using a case-control or retrospective design,
which are vulnerable to recall bias. A nested matched
case-control study conducted using the large European
Prospective Investigation into Cancer and Nutrition
(EPIC) prospective database found that diets of high
sugar and soft drink intake and low vegetable intake
were associated with an increased risk of ulcerative
colitis.5 A prospective study using data from the Nurses
Health Study II cohort found that participants with a
“prudent” dietary pattern in high school (higher intake
of vegetables, fibre, and fish) showed a lower risk of
subsequent Crohn’s disease.42 A French study using the
NutriNet-Sante prospective cohort did not find higher
intake of ultra-processed foods among participants
who subsequently developed IBD compared with those
who did not, after adjustment for confounders, but this
study might have been underpowered because of too
few participants (n=75) with IBD.15
We also found higher intake of fried food to be
associated with higher risk of IBD. This association
might exist because many fried foods are also processed
(eg, chicken nuggets, French fries). It could be that
the action of frying and the processing of oil leads to
7
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P trend
0.12
0.006
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Strengths and limitations of this study
We investigated dietary risk factors for IBD in a
large prospective multinational cohort study. The
study design overcomes the limitations of many
of the existing studies in this specialty, which are
retrospective or case-control in design and restricted
to homogenous populations with limited external
validity.10 The longitudinal design of our study allowed
us to focus on people with incident IBD and to use
medical record review and central adjudication to
validate a sample of the diagnoses. Information on diet
was collected at baseline before diagnosis to minimise
risk of bias from reverse causation or recall bias.
We excluded participants who received a diagnosis
within one year of the baseline FFQ assessment to
account for the possibility of dietary changes related
to gastrointestinal symptoms that would later lead to a
diagnosis of IBD. Validated, standardised, and country
specific questionnaires were used for collection of
dietary information. Because other baseline covariates
on univariable analysis were found to be associated
with risk of IBD, including smoking status and location,
the validity of our study findings was increased.53 54 We
also identified other factors on univariable analysis,
such as alcohol intake and BMI, that were significant
but possibly correlated with other confounding factors
and when put into a multivariable model were no longer
associated with risk of IBD (analyses not shown).
8

Nonetheless, our study also has some potential
limitations. Owing to the age of participants in
the PURE study (35-70 years), incident Crohn’s
disease was observed in a relatively small number of
participants, which might have resulted in our study
being underpowered to determine risk factors for
Crohn’s disease. Furthermore, the generalisability of
these findings to patients who develop IBD at an earlier
age (children or young adulthood) is unclear. We did,
however, run subgroup analyses to determine whether
age was an effect modifier and found similar increased
hazard ratios for risk of IBD in those younger than or
older than 50 years. Only a sample of participants
with IBD were selected for validation, which increases
the risk of misclassification for cases that did not
undergo verification processes, but misclassification of
participants with IBD would tend to bias associations
to the null and this should not affect our findings. We
did not account for dietary changes over time, but
dietary intake as measured by the FFQ has been shown
to be relatively stable over time.55 During follow-up,
however, some of the diets in included countries might
have become partly westernised, which could lead
to inaccuracy in capturing the degree of processed
foods and their influence in these participants. FFQs
are not an ideal instrument for measuring absolute
intake—however, FFQs might still be useful to assess
relative intake, so our results should be taken in the
context of higher versus lower levels of ultra-processed
food intake.56 Multiple comparisons were made and
a possibility remains of positive results being found
owing to chance alone. Our findings did, however,
show a high level of statistical significance, thereby
providing some reassurance that our observations
are probably real. Lastly, although we were able to
adjust for many variables through our multivariable
models, owing to the observational nature of our
study the possibility of residual bias from unmeasured
(eg, antibiotic use in early childhood), imprecisely
measured, or unknown confounders remains.

Conclusions
In this study, higher ultra-processed food intake
was associated with higher risk of IBD. As white
meat, unprocessed red meat, dairy, starch, and fruit,
vegetables, and legumes were not found to be associated
with development of IBD, this study suggests that it
might not be the food itself that confers this risk but
rather the way the food is processed or ultra-processed.
A possibility also remains of residual confounding
owing to unmeasured or unknown confounders.
Further studies are needed to identify specific potential
contributory factors among processed foods that might
be responsible for the observed associations in our
study.
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modification of nutrients within the food.43 44 The type
and quality of oil used might also be relevant.45
In our study, intake of white meat, unprocessed
red meat, dairy, starch, and fruit, vegetables, and
legumes were not found to be associated with risk of
IBD. Recent meta-analyses that included high quality
studies found no associations between pre-illness
intake of carbohydrates, sugar, protein, or fat for either
Crohn’s disease or ulcerative colitis.46-48 Although
some studies have suggested increased meat intake
could increase the risk of IBD,10 16 and higher fruit and
vegetable intake might be protective,17 18 these findings
have not been found consistently in all studies that
have examined this potential association.10 49 50 This
finding could be partly due to study design limitations,
particularly in case-control studies where the selection
of controls might have an impact on associations being
evaluated.
For positive associations found in our study, similar
directional effects were observed for Crohn’s disease
and ulcerative colitis. Overall, a lower number of
participants with Crohn’s disease were observed in our
study (n=90) compared with ulcerative colitis (n=377).
Reasons for the higher incidence of ulcerative colitis
compared with Crohn’s disease in our study probably
reflects participants being from developing nations,
where ulcerative colitis is known to be relatively more
prevalent.51 Furthermore, the age of participants in the
PURE study was 35-70 years, and the risk of Crohn’s
disease is lower at older ages, whereas ulcerative colitis
has a bimodal peak, with many patients receiving a
diagnosis in their 50s and 60s.1 52
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